Partial efficacy of a Brazilian coralsnake antivenom and varespladib in neutralizing distinct toxic effects induced by sublethal Micrurus dumerilii carinicauda envenoming in rats

Toxicon. 2022 Jul 15:213:99-104. doi: 10.1016/j.toxicon.2022.04.014. Epub 2022 Apr 27.

Abstract

In this work, we reported the efficacy of a combination of Brazilian therapeutic coralsnake antivenom (CAV) and varespladib (phospholipase A2 inhibitor - VPL) in partially neutralizing selected toxic effects of Micrurus dumerilii carinicauda coralsnake venom in rats. Venom caused local myonecrosis and systemic neurotoxicity, nephrotoxicity, and hepatotoxicity within 2 h of injection. CAV and VPL administered separately failed to prevent most of these alterations. However, a combination of CAV plus VPL offered variable protection against venom-induced coagulation disturbances, leukocytosis, and renal-hepatic morphological alterations.

Keywords: Antivenom; Coralsnake venom; Neutralization; Systemic envenomation; Varespladib.

MeSH terms

  • Acetates
  • Animals
  • Antivenins / pharmacology
  • Brazil
  • Coral Snakes*
  • Elapid Venoms / toxicity
  • Indoles
  • Keto Acids
  • Rats

Substances

  • Acetates
  • Antivenins
  • Elapid Venoms
  • Indoles
  • Keto Acids
  • varespladib